(R,S)-PHPNECA
|
R611151-25mg
|
Moligand™ |
155036-68-3 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(R,S)-4-PPG
|
R611150-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(R,S)-4-PPG
|
R611150-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(R)-zacopride
|
R611147-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(R)-zacopride
|
R611147-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(R)-flurocarazolol
|
R611145-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(R)-flurocarazolol
|
R611145-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(-)-(R)-efonidipine
|
R611144-5mg
|
Moligand™ |
128194-13-8 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(-)-(R)-efonidipine
|
R611144-25mg
|
Moligand™ |
128194-13-8 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(R)-DOI
|
R611143-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(R)-DOI
|
R611143-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(R)-ARN2508
|
R611142-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(R)-ARN2508
|
R611142-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(R)-α-methylhistamine
|
R611141-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(R)-α-methylhistamine
|
R611141-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(3R)-1-[3-[[3-amino-6-(2-fluoro-5-propan-2-yloxyphenyl)pyrazine-2-carbonyl]amino]pyridin-4-yl]piperidine-3-carboxylic acid
|
R610621-5mg
|
Moligand™ |
2041073-22-5 |
5mg
|
¥ 425.9
|
期货,请咨询 |
阿拉丁 |
(3R)-1-[3-[[3-amino-6-(2-fluoro-5-propan-2-yloxyphenyl)pyrazine-2-carbonyl]amino]pyridin-4-yl]piperidine-3-carboxylic acid
|
R610621-25mg
|
Moligand™ |
2041073-22-5 |
25mg
|
¥ 1582.9
|
期货,请咨询 |
阿拉丁 |
4-[4-[[(3R)-3-methyl-4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methyl]-1H-pyrazol-5-yl]benzonitrile
|
R610620-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
4-[4-[[(3R)-3-methyl-4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methyl]-1H-pyrazol-5-yl]benzonitrile
|
R610620-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
[(2R,3S,4S)-4-anilino-2-ethyl-3-methyl-3,4-dihydro-2H-quinolin-1-yl]-(3,5-dichlorophenyl)methanone
|
R610568-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
[(2R,3S,4S)-4-anilino-2-ethyl-3-methyl-3,4-dihydro-2H-quinolin-1-yl]-(3,5-dichlorophenyl)methanone
|
R610568-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
(2R)-N-(4-bromophenyl)-2-{5-[(3-methoxyphenyl)methyl]-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl}-2-phenylacetamide
|
R609524-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
(2R)-N-(4-bromophenyl)-2-{5-[(3-methoxyphenyl)methyl]-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl}-2-phenylacetamide
|
R609524-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
2-[(2R)-1-{2-[tris(4-methoxyphenyl)methoxy]ethyl}pyrrolidin-2-yl]acetic acid
|
R609518-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |